Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial - Traboulsee, A; Greenberg, B M; Bennett, J L (Lancet Neurol, 2020)